You Previously Qualified for a Small Dispenser DSCSA Exemption. Now What?
This article, originally published in Pharmacy Times, explores the DSCSA exemption for small dispensers and outlines their current and future regulatory obligations. It highlights the importance of staying compliant with key DSCSA requirements, including verifying trading partner licenses, maintaining product tracing documentation, and preparing for full electronic interoperability by the 2026 deadline.Inmar Intelligence Launches Commerce Fitscore™, Removing Subjectivity in Creator Selection
The first solution of its kind to identify creators based on their audience’s actual purchasing behavior. Inmar Intelligence, a leading data and technology company, today announced Commerce Fitscore™, the first solution of its kind that removes the subjectivity in creator selection and aligns creator selection with actual purchase behavior. Powered by Inmar’s first-party transactional data, Commerce Fitscore™ enables brands and retailers to select creators based on their audiences’ likelihood to drive sales performance.
Rethinking Healthcare: Why Pharmacists Should Be Recognized as Providers
The article advocates for recognizing pharmacists as healthcare providers, enabling them to offer more comprehensive care and help address physician shortages, especially in underserved areas. This change would improve patient outcomes and expand healthcare access.Inmar Intelligence Appoints Pia Ostos as Chief Performance Officer
Inmar Intelligence, a leading data and technology company, is pleased to announce the appointment of Pia Ostos to the newly created role of Chief Performance Officer (CPO). This strategic addition to the Executive Leadership Team reflects Inmar’s ongoing commitment to delivering unparalleled value to its customers, partners, and stakeholders.
PBMs on Notice: NYCBS Victory Signals Major Changes Ahead
New York Cancer and Blood Specialists' $22M win against Caremark challenges PBM DIR fees, sparking potential legal and regulatory shifts. While a major victory for pharmacies, eliminating DIR fees could raise Medicare Part D premiums. Legislative and regulatory changes may reshape PBM practices and impact both pharmacies and beneficiaries.
The Final Stretch: Is Your Pharmacy Ready for DSCSA Compliance?
As the November 27, 2024, deadline for full DSCSA compliance looms, the pharmacy industry finds itself in a critical phase of preparation. The recent NACDS Total Store Expo (TSE) in Boston revealed that many pharmacies are facing significant challenges, with the clock ticking down rapidly.
Here’s How We Get Private Insurers to Buy In on Value-Based Care
Value-based care is seen as healthcare’s next evolution, prioritizing whole-health outcomes over the usual volume of symptom treatments. This approach has profound implications for cost management, patient satisfaction, and overall healthcare quality. However, transitioning from traditional fee-for-service models to value-based care faces challenges, particularly regarding payer motivation and long-term investment. The growing attention around “food as medicine” is part of this, and pharmacists have an opportunity to contribute.